Prognosis and risk stratification in young papillary thyroid carcinoma patients

Endocrine Journal

Volumn 55, Issue 2, 2008, Pages 269-275

  Kou, Sheng Fong ^a   Chao, Tzu Chieh ^b   Hsueh, Chuen ^b   Chuang, Wen Yu ^b   Yang, Chung Han ^b   Lin, Jen Der ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cancer staging; Papillary thyroid cancer; Pediatric oncology; Prognosis; Tnm classification

Indexed keywords

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ANALYTIC METHOD; ARTICLE; BRAIN METASTASIS; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLARY THYROID CARCINOMA; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; THYROID CARCINOMA; THYROIDECTOMY;

ADOLESCENT; CARCINOMA, PAPILLARY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TAIWAN; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 43449112707     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-127     Document Type: Article

References (28)

1. Pacini F, Vorontsova T, Demidchik EP, Molinaro E, Agate L, Romei C, Shavrova E, Cherstvoy ED, Ivashkevitch Y, Kuchinskaya E, Schlumberger M, Ronga G, Filesi M, Pinchera A (1997) Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 82: 3563-3569.
2. Demidchik YE, Demidchik EP, Reiners C, Biko J, Mine M, Saenko VA, Yamashita S (2006) Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 243: 525-532.
3. La Quaglia MP, Corbally MT, Heller G, Exelby PR, Brennan MF (1988) Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery 104: 1149-1156.
4. Brink JS, van Heerden JA, McIver B, Salomao DR, Farley DR, Grant CS, Thompson GB, Zimmerman D, Hay ID (2000) Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 128: 881-887.
5. Newman KD, Black T, Heller G, Azizkhan RG, Holcomb GW, Sklar C, Vlarnis V, Haase GM, La Quaglia MP (1998) Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis. A report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 237: 533-541.
6. Schlumberger M, De Vathaire F, Travagli JP, Vassal G, Lemerle J, Parmentier C, Tubiana M (1987) Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 65: 1088-1094.
7. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: 418-428.
8. Sobin LH, Wittekind CH (2002) UICC: TNM classification of malignant tumors. 6th ed. Wiley-Liss, New York: 52-56.
9. Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
10. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1057.
11. DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71: 414-424.
12. Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M, the EUROCARE working group (2005) Childhood cancer survival trends in Europe: A EUROCARE working group study. J Clin Oncol 23: 3742-3751.
13. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M (2001) Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86: 1072-1077.
14. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Ando S, Maggiolini M (2006) 17 beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 70: 1414-1423.
15. Samuel AM, Sharma SM (1991) Differentiated thyroid carcinomas in children and adolescents. Cancer 67: 2186-2190.
16. Shapiro NL, Bhattacharyya N (2005) Population-based outcomes for pediatric thyroid carcinoma. Laryngoscope 115: 337-340.
17. Collini P, Mattavelli F, Pellegrinelli A, Barisella M, Ferrari A, Massimino M (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30: 1420-1426.
18. Gilliland FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79: 564-573.
19. Lin JD, Chao TC, Sun JH, Ho C, Weng HF (2000) Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan. Oncology 58: 280-285.
20. Newman KD, Black T, Heller G, Azizkhan RG, Holcomb GW 3rd, Sklar C, Vlamis V, Haase GM, La Quaglia MP (1998) Differentiated thyroid cancer: determinants of disease progression in patients 21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 227: 533-541.
21. Alessandri AJ, Goddard KJ, Blair GK, Fryer CJ, Schultz KR (2000) Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol 35: 41-46.
22. Passler C, Scheuba C, Asari R, Kaczirek K, Kaserer K, Niederle B (2005) Importance of tumour size in papillary and follicular thyroid cancer. Br J Surg 92: 184-189.
23. Popovtzer A, Shpitzer T, Bahar G, Feinmesser R, Segal K (2006) Thyroid cancer in children: Management and outcome experience of a referral center. Otolaryngol Head Neck Surg 135: 581-584.
24. Lin JD, Kao PF, Chao TC (1998) The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma. Br J Radiol 71: 307-313.
25. Hoyes KP, Owens SE, Millns MM, Allan E (2004) Differentiated thyroid cancer: radioiodine following lobectomy - a clinical feasibility study. Nucl Med Commun 25: 245-251.
26. Randolph GW, Daniels GH (2002) Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid 12: 989-996.
27. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, the European Thyroid Cancer Taskforce (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154: 787-803.
28. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91: 2892-2899.